Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

1 week ago 7

Maham Fatima

Sun, April 12, 2026 astatine 1:43 PM CDT 2 min read

Gilead Sciences Inc. (NASDAQ:GILD) is 1 of the 8 Best Quality Stocks to Buy According to Hedge Funds. Gilead Sciences Inc. (NASDAQ:GILD) is 1 of the champion prime stocks to bargain according to hedge funds. On April 9, Tempus AI (NASDAQ:TEM) announced an expanded, multi-year collaboration with Gilead Sciences to accelerate Gilead’s oncology probe and improvement pipeline. The statement builds connected erstwhile enactment wherever Gilead utilized Tempus’ de-identified multimodal information for proceedings design, biomarker strategies, and wellness outcomes analysis.

Under this caller enterprise-wide mandate, Gilead gains broader entree to Tempus’ AI-driven Lens level and dedicated analytical services crossed aggregate crab indications. The concern aims to usage Tempus’ immense room of real-world information to uncover biologic insights that tin amended objective decision-making.

By integrating Gilead’s technological expertise with precocious information insights, the companies question to summation the probability of occurrence for caller crab therapies. Patrick Loerch, SVP of Clinical Data Science astatine Gilead Sciences Inc. (NASDAQ:GILD), emphasized that the collaboration focuses connected putting patients astatine the halfway of innovation done data-informed research. The collaboration underscores the increasing relation of AI and real-world grounds successful modern cause improvement and precision medicine.

Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

Gilead Sciences Inc. (NASDAQ:GILD) is simply a cause shaper that develops medicines for unmet aesculapian needs. The institution provides treatments for HIV-1, chronic hepatitis C, superior biliary cholangitis, chronic hepatitis B, and superior invasive fungal infections. It besides offers T-cell and CAR T-cell therapies for big patients, intravenous injections, and treatments for COVID-19.

Tempus AI Inc. (NASDAQ:TEM) is simply a healthcare exertion institution that uses artificial quality to beforehand precision medicine.

While we admit the imaginable of GILD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article